BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38599642)

  • 21. [Safety and effectiveness of transoral robotic surgery for oropharyngeal cancer: a pilot study].
    Xu K; Cai LJ; Chen H; Li YY; Wang ZB; Huang HY; Chu HQ; Cui YH; Liu Z; Lu X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Feb; 55(2):109-115. PubMed ID: 32074748
    [No Abstract]   [Full Text] [Related]  

  • 22. Specimen-Based Resection Margins and Local Control during Transoral Robotic Surgery for Oropharyngeal HPV-Mediated Squamous Cell Carcinoma.
    Magliocca KR; Kaka AS; Barrow EM; Studer MB; Griffith CC; Ernst J; Meade T; Balicki A; Boyce BJ; Schmitt NC; Bur AM; Schmitt AC; Jackson R; Steuer CE; Beitler JJ; Patel MR
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(2):80-87. PubMed ID: 36538901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
    Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma-A large observational single-centre series from the United Kingdom.
    O'Hara J; Warner L; Fox H; Hamilton D; Meikle D; Counter P; Robson A; Goranova R; Iqbal S; Kelly C; Robinson M; Paleri V
    Clin Otolaryngol; 2021 Sep; 46(5):1005-1012. PubMed ID: 33754476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
    Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
    Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemotherapy and transoral robotic surgery for the posterior pharyngeal wall carcinoma.
    Costantino A; Meliante PG; Sampieri C; Lee K; Ralli M; De Vincentiis M; De Virgilio A; Kim SH
    Eur Arch Otorhinolaryngol; 2023 Oct; 280(10):4649-4655. PubMed ID: 37395758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
    Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
    Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage Transoral Robotic Surgery for Recurrent or Residual Head and Neck Squamous Cell Carcinoma: A Single Institution Experience.
    Dabas S; Dewan A; Ranjan R; Dewan AK; Shukla H; Sinha R
    Asian Pac J Cancer Prev; 2015; 16(17):7627-32. PubMed ID: 26625773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
    Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
    Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
    Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preliminary experience of transoral robotic surgery for oropharyngeal carcinoma].
    Zhang YB; Rai RAI; Zhi YH; Zhang B
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 May; 57(5):559-564. PubMed ID: 35610673
    [No Abstract]   [Full Text] [Related]  

  • 32. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
    Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U
    Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trans oral robotic surgery for oropharyngeal cancer: A multi institutional experience.
    De Virgilio A; Pellini R; Cammaroto G; Sgarzani R; De Vito A; Gessaroli M; Costantino A; Petruzzi G; Festa BM; Campo F; Moretti C; Pichi B; Mercante G; Spriano G; Vicini C; Meccariello G
    Eur J Surg Oncol; 2023 Sep; 49(9):106945. PubMed ID: 37331862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transoral robotic retropharyngeal node dissection in oropharyngeal squamous cell carcinoma: Patterns of metastasis and functional outcomes.
    Troob S; Givi B; Hodgson M; Mowery A; Gross ND; Andersen PE; Clayburgh D
    Head Neck; 2017 Oct; 39(10):1969-1975. PubMed ID: 28758272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
    Swisher-McClure S; Lukens JN; Aggarwal C; Ahn P; Basu D; Bauml JM; Brody R; Chalian A; Cohen RB; Fotouhi-Ghiam A; Geiger G; Gershowitz J; Livolsi V; Mitra N; Montone K; Newman J; Ojerholm E; O'Malley B; Rajasekaran K; Tan E; Weinstein G; Lin A
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):725-732. PubMed ID: 31785337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
    Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive Margins by Oropharyngeal Subsite in Transoral Robotic Surgery for T1/T2 Squamous Cell Carcinoma.
    Persky MJ; Albergotti WG; Rath TJ; Kubik MW; Abberbock S; Geltzeiler M; Kim S; Duvvuri U; Ferris RL
    Otolaryngol Head Neck Surg; 2018 Apr; 158(4):660-666. PubMed ID: 29182490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A New Clinical Trial of Neoadjuvant Chemotherapy Combined With Transoral Robotic Surgery and Customized Adjuvant Therapy for Patients With T3 or T4 Oropharyngeal Cancer.
    Park YM; Jung CM; Cha D; Kim DH; Kim HR; Keum KC; Cho NH; Kim SH
    Ann Surg Oncol; 2017 Oct; 24(11):3424-3429. PubMed ID: 28718033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Swallowing Function Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Carcinoma: A 2-Year Follow-up.
    Lee E; Gorelik D; Crowder HR; Badger C; Schottler J; Li NW; Siegel R; Sadeghi N; Goodman JF; Thakkar PG; Joshi AS
    Otolaryngol Head Neck Surg; 2022 Aug; 167(2):298-304. PubMed ID: 34752157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transoral robotic surgery: implementation as a tool in head and neck surgery - a single-centre Australian experience.
    Hirshoren N; Ruskin O; Fua T; Kleid S; Magarey M; Dixon B
    ANZ J Surg; 2018 Nov; 88(11):1129-1134. PubMed ID: 27766718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.